D. N. Baxter

885 total citations
20 papers, 569 citations indexed

About

D. N. Baxter is a scholar working on Epidemiology, Health and Virology. According to data from OpenAlex, D. N. Baxter has authored 20 papers receiving a total of 569 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Epidemiology, 4 papers in Health and 4 papers in Virology. Recurrent topics in D. N. Baxter's work include Influenza Virus Research Studies (5 papers), Rabies epidemiology and control (4 papers) and Vaccine Coverage and Hesitancy (4 papers). D. N. Baxter is often cited by papers focused on Influenza Virus Research Studies (5 papers), Rabies epidemiology and control (4 papers) and Vaccine Coverage and Hesitancy (4 papers). D. N. Baxter collaborates with scholars based in United Kingdom. D. N. Baxter's co-authors include Martin Maiden, J. Claire Cameron, K.J. Cann, James M. Stuart, Keith Neal, George Kafatos, Jenny MacLennan, M.R. Evans, Richard J. Roberts and Nick Andrews and has published in prestigious journals such as Analytical Chemistry, Journal of Allergy and Clinical Immunology and The British Journal of Psychiatry.

In The Last Decade

D. N. Baxter

19 papers receiving 532 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. N. Baxter United Kingdom 9 275 220 84 69 66 20 569
Julie van Schalkwyk Canada 20 722 2.6× 370 1.7× 56 0.7× 65 0.9× 78 1.2× 57 1.5k
Mary K. Sawyer United States 17 474 1.7× 282 1.3× 183 2.2× 49 0.7× 143 2.2× 26 1.0k
Karen M. Kaplan United States 14 491 1.8× 39 0.2× 47 0.6× 65 0.9× 18 0.3× 28 982
Martti Valle Finland 11 516 1.9× 36 0.2× 60 0.7× 67 1.0× 114 1.7× 13 764
Bradley J. Sullivan United States 14 573 2.1× 108 0.5× 27 0.3× 23 0.3× 52 0.8× 21 755
Richard O. Cannon United States 12 332 1.2× 95 0.4× 81 1.0× 128 1.9× 120 1.8× 16 1.1k
Carina A. Rodriguez United States 16 482 1.8× 180 0.8× 165 2.0× 40 0.6× 112 1.7× 48 1.0k
Carol Smith United States 11 123 0.4× 21 0.1× 118 1.4× 44 0.6× 174 2.6× 21 595
Bernard Marcel Diop Senegal 14 183 0.7× 71 0.3× 158 1.9× 12 0.2× 19 0.3× 79 608
Julie T. Guarnizo United States 6 186 0.7× 264 1.2× 70 0.8× 184 2.7× 28 0.4× 6 580

Countries citing papers authored by D. N. Baxter

Since Specialization
Citations

This map shows the geographic impact of D. N. Baxter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. N. Baxter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. N. Baxter more than expected).

Fields of papers citing papers by D. N. Baxter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. N. Baxter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. N. Baxter. The network helps show where D. N. Baxter may publish in the future.

Co-authorship network of co-authors of D. N. Baxter

This figure shows the co-authorship network connecting the top 25 collaborators of D. N. Baxter. A scholar is included among the top collaborators of D. N. Baxter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. N. Baxter. D. N. Baxter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Linehan, Mary, Ulugbek Nurmatov, Timothy L Frank, et al.. (2013). Does BCG vaccination protect against childhood asthma? Final results from the Manchester Community Asthma Study retrospective cohort study and updated systematic review and meta-analysis. Journal of Allergy and Clinical Immunology. 133(3). 688–695.e14. 45 indexed citations
2.
Baxter, D. N., et al.. (2010). Referrals to a pediatric immunization service: Findings from a practice-based audit of a UK specialist immunization clinic. Human Vaccines. 6(5). 420–424. 6 indexed citations
3.
Linehan, Mary, Timothy L Frank, Michelle L Hazell, et al.. (2007). Is the prevalence of wheeze in children altered by neonatal BCG vaccination?. Journal of Allergy and Clinical Immunology. 119(5). 1079–1085. 38 indexed citations
4.
Kennedy, L. J., Mark Lunt, Lorraine M. McElhinney, et al.. (2007). Factors influencing the antibody response of dogs vaccinated against rabies. Vaccine. 25(51). 8500–8507. 99 indexed citations
5.
Linehan, Mary, Timothy L Frank, Michelle L Hazell, et al.. (2006). Reduced Prevalence of Childhood Wheeze in Children Given Neonatal BCG Vaccination. Journal of Allergy and Clinical Immunology. 117(2). S181–S181. 1 indexed citations
6.
MacLennan, Jenny, George Kafatos, Keith Neal, et al.. (2006). Social Behavior and Meningococcal Carriage in British Teenagers. Emerging infectious diseases. 12(6). 950–957. 181 indexed citations
7.
Baxter, D. N., et al.. (2002). Standardising immunisation practices: A preliminary survey of the role of Patient Group Directions. Research Explorer (The University of Manchester). 4(2). 52–54. 1 indexed citations
8.
Baxter, D. N.. (1996). The Mortality Experience of Individuals on the Salford Psychiatric Case Register. The British Journal of Psychiatry. 168(6). 772–779. 72 indexed citations
9.
Baxter, D. N.. (1996). Measles immunization in children with a history of egg allergy. Vaccine. 14(2). 131–134. 48 indexed citations
10.
Baxter, D. N.. (1994). Pertussis immunisation of children with histories of neurological problems. BMJ. 309(6969). 1619.1–1619.1. 3 indexed citations
11.
Baxter, D. N.. (1990). Improving immunisation uptake in the United Kingdom. Public Health. 104(4). 267–274. 9 indexed citations
12.
Baxter, D. N., et al.. (1990). Patterns of behaviour amongst injecting drug users—implications for HIV. Public Health. 104(5). 321–325. 5 indexed citations
13.
Baxter, D. N., et al.. (1988). Acute Hepatitis B infection in Stockport during 1984 and 1985. Journal of Public Health. 10(4). 298–305. 5 indexed citations
14.
Baxter, D. N. & Alan C. Gibbs. (1987). How are the sub-unit pertussis vaccines to be evaluated?. Epidemiology and Infection. 99(2). 477–484. 2 indexed citations
15.
Baxter, D. N. & Stephen Morton. (1987). An outbreak of S. indiana in a maternity unit: implications for control policies. Journal of Public Health. 9(4). 365–371. 5 indexed citations
16.
Baxter, D. N.. (1984). The deleterious effects of dogs on human health: dog-associated injuries. Journal of Public Health. 6(1). 29–36. 23 indexed citations
17.
Baxter, D. N. & Ian Leck. (1984). The deleterious effects of dogs on human health: 2. Canine zoonoses. Journal of Public Health. 6(3). 185–197. 19 indexed citations
18.
Baxter, D. N.. (1984). The deleterious effects of dogs on human health: 3. Miscellaneous problems and a control programme. Journal of Public Health. 6(3). 198–203. 4 indexed citations
19.
Baxter, D. N., et al.. (1979). Variable Volume Automatic Sample Dispenser for an Electrothermal Atomizer. Instrumentation Science & Technology. 9(1). 71–89. 2 indexed citations
20.
Crouch, S. R., et al.. (1978). Simple hardware control approach for sequencing chemical instruments. Analytical Chemistry. 50(2). 291–300. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026